Research ArticleArticle
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
Maria Konsta, Michael T. Nurmohamed, Alexios Iliopoulos, Petros P. Sfikakis, J. Christiaan van Denderen, Ingrid Visman, Grigorios T. Sakelariou and Irene E. van der Horst-Bruinsma
The Journal of Rheumatology November 2022, jrheum.220061; DOI: https://doi.org/10.3899/jrheum.220061
Maria Konsta
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Michael T. Nurmohamed
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Alexios Iliopoulos
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Petros P. Sfikakis
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
J. Christiaan van Denderen
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Ingrid Visman
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Grigorios T. Sakelariou
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Irene E. van der Horst-Bruinsma
M. Konsta, MD, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands, and Department of Rheumatology Veterans Administration Hospital, Athens, Greece, and Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; M.T. Nurmohamed, MD, PhD, J.C. van Denderen, MD, PhD, I. Visman, PhD, Department of Rheumatology and Immunology, Amsterdam UMC, Amsterdam, the Netherlands; A. Iliopoulos, MD, G.T. Sakelariou, MD, PhD, Department of Rheumatology Veterans Administration Hospital, Athens, Greece; P.P. Sfikakis, MD, PhD, Joint Rheumatology Program, National Kapodistrian University of Athens Medical School, Athens, Greece; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Radboud University Medical Centre, Nijmegen, the Netherlands. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. I.E. van der Horst-Bruinsma, Radboud University Medical Centre, Department of Rheumatology, P.O. Box 9101, NL 6500 HB Nijmegen, the Netherlands. Email: irene.vanderhorst-Bruinsma@radboudumc.nl. Accepted for publication September 2, 2022.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
Maria Konsta, Michael T. Nurmohamed, Alexios Iliopoulos, Petros P. Sfikakis, J. Christiaan van Denderen, Ingrid Visman, Grigorios T. Sakelariou, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Nov 2022, jrheum.220061; DOI: 10.3899/jrheum.220061
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
Maria Konsta, Michael T. Nurmohamed, Alexios Iliopoulos, Petros P. Sfikakis, J. Christiaan van Denderen, Ingrid Visman, Grigorios T. Sakelariou, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Nov 2022, jrheum.220061; DOI: 10.3899/jrheum.220061